This study offers insights into real-world sequential AT use in Canadian RA care. First-line AT is associated with superior survival and effectiveness; however, subsequent therapies continue to provide important clinical benefits. These findings support the value of personalised sequential treatment strategies and highlight the need for further research to inform future RA management guidelines.